In the last couple of decades, dynamic bone disease has become the most prominent subtype of renal osteodystrophy seen in patients undergoing dialysis. Earlier, the aluminum-induced low bone turnover disease was frequently seen before the advent of aluminum-free dialysate solutions and the use of non-aluminum phosphate binders.

The overall trend has also shifted from hyperparathyroidism induced high bone turnover diseases to adynamic bone disease.